November 2012 FDA Recall Fluorouracil by Taro Pharmaceuticals U.s.a., Inc.
D-086-2013 - Product Lacks Stability

This Class II drug recall was voluntarily initiated by Taro Pharmaceuticals U.s.a., Inc. on November 21, 2012 for the product Fluorouracil. The FDA reported the reason for recall as product lacks stability. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-086-2013

Reason for Recall
Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Initiated
11-21-2012
Reported
12-12-2012
Quantity
39,982 Tubes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Taro Pharmaceuticals U.S.A., Inc.
Nationwide and Puerto Rico
Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.

Batch or Lot Expiration Information

Lot# s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014.